Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Ipsen
  6. News
  7. Most relevant
    IPN   FR0010259150

IPSEN

(IPN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about IPSEN
06/18IPSEN  : A year-long partnership with the ISPC
PU
06/17IPSEN  : launches Perspectives Matter around World Kidney Cance...
PU
06/14ISPRM 2021 : New Ipsen analysis highlights potential treatment gap in adults liv..
AQ
06/11IPSEN  : Finds Potential Treatment Gap Among Spasticity Patients in US
MT
06/11IPSEN  : ISPMR 2021 – 11 June 2021.pdf
PU
06/07IPSEN  : Exelixis Say Phase 3 Trial of Cabozantinib Drug in Differentiated Thyro..
MT
06/07IPSEN  : Exelixis COSMIC-311 ASCO – 7 June 2021.pdf
PU
06/05IPSEN  : World Environment Day 2021
PU
05/31TODAY'S ANALYST RECOMMENDATIONS : Advanced Micro Devices, AstraZeneca, Bodycote,..
05/31IPSEN  : US FDA Accepts Ipsen's Approval Request For Ultra-Rare Genetic Disorder..
MT
05/31IPSEN : Ex-dividend day for final dividend
FA
05/28IPSEN  : Palovarotene FDA acceptance – 28 May 2021.pdf
PU
05/28IPSEN  : Compensation policy for corporate officers, result of vote SM – 2..
PU
05/28IPSEN  : Information relating to compensation elements of ALC – 28 mai 202..
PU
05/28IPSEN  : Information relating to compensation elements of DL – 28 mai 2021..
PU
05/28IPSEN  : Our 2020 Integrated Annual Report now available for download
PU
05/27IPSEN  : Press release post SM – 27 May 2021.pdf
PU
05/27IPSEN  : Combined Shareholders' Meeting of 27 May 2021
PU
05/27IPSEN  : Information related to the Combined Shareholders' Meeting of...
PU
05/27IPSEN  : Description of the share repurchase program – 27 May 2021.pdf
PU
05/17IPSEN  : Signes production site has received the Shingo (Gold) Award
PU
05/12IPSEN  : opts-in to join Exelixis with ongoing development of Cabometyx for peop..
AQ
05/12IPSEN  : Information related to the Combined Shareholders' Meeting of 27 May 202..
PU
05/12IPSEN  : to Collaborate With Exelixis in Late-Stage Thyroid Cancer Study
MT
05/03KARYOPHARM THERAPEUTICS  : Reports Narrower Q1 Loss, Higher Revenue, Names Richa..
MT
04/27IPSEN  : What working in rare disease has taught me about supporting better FOP ..
PU
04/27After Tesla: Microsoft and Alphabet
04/22GLOBAL MARKETS LIVE : Chevron, Toyota, Sony...
04/22IPSEN  : Q1 Sales Climb 6% Despite COVID-19 Impact
MT
04/21EARTH DAY 2021 : A moment to reflect, celebrate and – most importantly &nd..
PU
04/07U.S. Stock Futures Edge Up Ahead of Fed Minutes
DJ
04/06QUALITY OF LIFE : the full picture of patient health
PU
04/01IPSEN  : Fusion Pharmaceuticals Announces Closing of Acquisition of IPN-1087, a ..
AQ
04/01IPSEN S A  : European Commission approves Cabometyx in combination with Opdivo a..
AQ
04/01ROYALTY PHARMA  : Acquires Royalty Stake on Two GlaxoSmithKline Cancer Drugs
MT
04/01Royalty Pharma Acquires Royalty Interest in Cabometyx and Cometriq from GSK
DJ
03/31Exelixis Says Partner Ipsen Gets Regulatory Nod for Use of Cabometyx With Opd..
MT
03/31Ipsen Trades Higher After EU Approval of Kidney-Cancer Drug Combination
DJ
03/31IPSEN  : Kidney Cancer Combo Gets European Commission Approval
MT
03/30Arix leads USD152 million Series B financing for Pyxis Oncology
DJ
03/08IPSEN  : Statement on lanreotide decentralised procedure
PU
03/02FUSION PHARMACEUTICALS  : to Buy Ipsen's Intellectual Property, Assets Related T..
MT
03/02IPSEN  : Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087,..
AQ
03/01IPSEN  : announces the arrival of Gwenan White, EVP Communications & Public Affa..
PU
03/01IPSEN  : receives positive CHMP opinion recommending Cabometyx in combination wi..
AQ
02/26IPSEN  : Wins EMA's Positive Opinion for Cabometyx With Opdivo in Kidney Cancer ..
MT
02/26BRISTOL MYERS : CHMP Backs Opdivo/Cabometyx in Advanced Renal Cell Carcinoma
DJ
02/26IPSEN  : Receives Positive CHMP Opinion Recommending Cabometyx® in Combination W..
BU
02/24IPSEN  : A new language inviting you to understand more about the rare disease c..
PU
02/22IPSEN  : announces new data from the Phase II CLARINET FORTE study which demonst..
AQ
02/22IPSEN  : Releases New Positive Data from Phase II Clarinet Forte Trial
MT
02/22IPSEN  : Announces New Data from the Phase II CLARINET FORTE Study Which Demonst..
BU
02/11IPSEN  : Returns to FY20 Profit Amid Sales Growth
MT
02/11IPSEN  : FY2020 financial results
PU
02/11IPSEN  : delivered sales growth and margin expansion in 2020 – Focused on ..
PU
02/11IPSEN  : Delivered Sales Growth and Margin Expansion in 2020 - Focused on Execut..
BU
02/09IPSEN  : New data from pivotal Phase III CheckMate -9ER trial of Cabometyx in co..
AQ
02/09IPSEN  : Reports 'Superior' Results from Latest Clinical Trial for Advanced Rena..
MT
02/08IPSEN  : New data from pivotal Phase III CheckMate -9ER trial of Cabometyx® in c..
PU
02/08IPSEN : New Data From Pivotal Phase III CheckMate -9ER trial of Cabometyx® in Co..
BU
02/08Ipsen to showcase commitment to going beyond traditional outcome measures for..
AQ
02/05IPSEN  : to Showcase Commitment to Going Beyond Traditional Outcome Measures for..
BU
01/21IPSEN  : appoints Gwenan White as Executive Vice President Communications and Pu..
AQ
01/20IPSEN  : Appoints Gwenan White as Executive Vice President, Communications and P..
BU
01/19IPSEN  : Half-year Statement of IPSEN Liquidity Agreement With NATIXIS ODDO BHF
BU
01/18IPSEN  : TOXINS 2021, new analyses of pivotal Phase III trial data highlight lon..
AQ
01/15IPSEN  : Dysport Offers Long Response Duration At Approved Dose
MT
01/15TOXINS 2021 : New analyses of pivotal Phase III trial data highlight long durati..
BU
01/14IPSEN  : Why 2021 is the year for R&D progress
PU
2020IPSEN  : and the fight against corruption
PU
2020IPSEN  : receives FDA Fast Track designation for investigational irinotecan lipo..
AQ
2020France's Ipsen plans $3.6 billion investment in drugs pipeline
RE
2020IPSEN  : Receives US FDA Nod for Potential Small Cell Lung Cancer Treatment
MT
2020IPSEN  : to Focus on Oncology, Rare Disease and Neuroscience; Sales Poised to Gr..
MT
2020IPSEN  : new strategic priorities unveiled at virtual Capital Markets Day event
PU
1  2  3  4  5  6  7  8Next
Upcoming event on IPSEN